These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 30765420)

  • 1. Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.
    Korecki AJ; Hickmott JW; Lam SL; Dreolini L; Mathelier A; Baker O; Kuehne C; Bonaguro RJ; Smith J; Tan CV; Zhou M; Goldowitz D; Deussing JM; Stewart AF; Wasserman WW; Holt RA; Simpson EM
    Genetics; 2019 Apr; 211(4):1155-1177. PubMed ID: 30765420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.
    Yadav D; Conner JA; Wang Y; Saunders TL; Ubogu EE
    Vascul Pharmacol; 2024 Jun; 155():107369. PubMed ID: 38554988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a tamoxifen-inducible Cre-driver mouse strain for widespread and temporal genetic modification in adult mice.
    Ichise H; Hori A; Shiozawa S; Kondo S; Kanegae Y; Saito I; Ichise T; Yoshida N
    Exp Anim; 2016 Jul; 65(3):231-44. PubMed ID: 26923756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
    Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
    Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of transgenic mice expressing tamoxifen-inducible cre-fusion protein specifically in mouse liver.
    Zhu HZ; Chen JQ; Cheng GX; Xue JL
    World J Gastroenterol; 2003 Aug; 9(8):1844-7. PubMed ID: 12918135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.
    Lan ZJ; Xu X; Cooney AJ
    Biol Reprod; 2004 Nov; 71(5):1469-74. PubMed ID: 15215191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-Containing Eye Drops Successfully Trigger Cre-Mediated Recombination in the Entire Eye.
    Schlecht A; Leimbeck SV; Tamm ER; Braunger BM
    Adv Exp Med Biol; 2016; 854():495-500. PubMed ID: 26427451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Pmel-dependent conditional and inducible Cre-driver mouse line for melanocytic-targeted gene manipulation.
    Nasrin M; Ahmed O; Han X; Nojebuzzaman M; Abo-Ahmed AI; Yazawa S; Osawa M
    Pigment Cell Melanoma Res; 2023 Jan; 36(1):53-70. PubMed ID: 36318272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cre recombinase resources for conditional mouse mutagenesis.
    Smedley D; Salimova E; Rosenthal N
    Methods; 2011 Apr; 53(4):411-6. PubMed ID: 21195764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
    Zhao J; Nassar MA; Gavazzi I; Wood JN
    Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pou4f2 knock-in Cre mouse: A multifaceted genetic tool for vision researchers.
    Simmons AB; Bloomsburg SJ; Billingslea SA; Merrill MM; Li S; Thomas MW; Fuerst PG
    Mol Vis; 2016; 22():705-17. PubMed ID: 27390513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo.
    Wang J; Wang Y; Long J; Chang BH; Wilson MH; Overbeek P; Danesh FR
    Genesis; 2010 Jul; 48(7):446-51. PubMed ID: 20641128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ER-based double iCre fusion protein allows partial recombination in forebrain.
    Casanova E; Fehsenfeld S; Lemberger T; Shimshek DR; Sprengel R; Mantamadiotis T
    Genesis; 2002 Nov; 34(3):208-14. PubMed ID: 12395386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of
    Xu C; Li S; Cai Y; Lu J; Teng Y; Yang X; Wang J
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of
    Li YS; Meng RR; Chen X; Shang CL; Li HB; Zhang TJ; Long HY; Li HQ; Wang YJ; Wang FC
    G3 (Bethesda); 2019 Feb; 9(2):591-599. PubMed ID: 30591434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of
    Said R; Zheng L; Saunders T; Zeidler M; Papagerakis S; Papagerakis P
    J Dent Res; 2019 Aug; 98(9):1002-1010. PubMed ID: 31329049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.